Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Prevalence and risk factors associated with HIV and tuberculosis in people who use drugs in Abidjan, Ivory Coast.

Bouscaillou J, Evanno J, Prouté M, Inwoley A, Kabran M, N'Guessan T, Djé-Bi S, Sidibé S, Thiam-Niangoin M, N'guessan BR, Blanchetière P, Luhmann N.

Int J Drug Policy. 2016 Apr;30:116-23. doi: 10.1016/j.drugpo.2016.02.010.

PMID:
26964902
2.

A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

TEMPRANO ANRS 12136 Study Group., Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, Ouattara E, Anzian A, Ntakpé JB, Minga A, Kouame GM, Bouhoussou F, Emieme A, Kouamé A, Inwoley A, Toni TD, Ahiboh H, Kabran M, Rabe C, Sidibé B, Nzunetu G, Konan R, Gnokoro J, Gouesse P, Messou E, Dohoun L, Kamagate S, Yao A, Amon S, Kouame AB, Koua A, Kouamé E, Ndri Y, Ba-Gomis O, Daligou M, Ackoundzé S, Hawerlander D, Ani A, Dembélé F, Koné F, Guéhi C, Kanga C, Koule S, Séri J, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatounde N, Bleoué G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Assi R, Bakayoko A, Mahassadi A, Attia A, Oussou A, Mobio M, Bamba D, Koman M, Horo A, Deschamps N, Chenal H, Sassan-Morokro M, Konate S, Aka K, Aoussi E, Journot V, Nchot C, Karcher S, Chaix ML, Rouzioux C, Sow PS, Perronne C, Girard PM, Menan H, Bissagnene E, Kadio A, Ettiegne-Traore V, Moh-Semdé C, Kouame A, Massumbuko JM, Chêne G, Dosso M, Domoua SK, N'Dri-Yoman T, Salamon R, Eholié SP, Anglaret X.

N Engl J Med. 2015 Aug 27;373(9):808-22. doi: 10.1056/NEJMoa1507198.

3.

Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in Côte d'Ivoire, West Africa.

Danel C, Kabran M, Inwoley A, Badje A, Herrmann JL, Moh R, Lecarrou J, Gabillard D, Ntakpe JB, Deschamps N, Ouattara E, Perronne C, Eholie S, Anglaret X.

PLoS One. 2014 Oct 16;9(10):e107245. doi: 10.1371/journal.pone.0107245.

4.

Re-testing and misclassification of HIV-2 and HIV-1&2 dually reactive patients among the HIV-2 cohort of the West African Database to evaluate AIDS collaboration.

Tchounga BK, Inwoley A, Coffie PA, Minta D, Messou E, Bado G, Minga A, Hawerlander D, Kane C, Eholie SP, Dabis F, Ekouevi DK; WADA Collaboration..

J Int AIDS Soc. 2014 Aug 11;17:19064. doi: 10.7448/IAS.17.1.19064.

5.

Interest in Determining the CD34+ CD38- Phenotype in the Diagnosis and Prognosis of Acute Leukemia in Abidjan - Côte d'Ivoire.

Sawadogo D, Tolo A, Kassi H, Sangare M, Inwoley A.

Mediterr J Hematol Infect Dis. 2013 Apr 10;5(1):e2013023. doi: 10.4084/MJHID.2013.023.

6.

Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa.

Pantazis N, Morrison C, Amornkul PN, Lewden C, Salata RA, Minga A, Chipato T, Jaffe H, Lakhi S, Karita E, Porter K, Meyer L, Touloumi G; CASCADE Collaboration in EuroCoord and ANRS 1220 Primo-CI Study Group..

PLoS One. 2012;7(3):e32369. doi: 10.1371/journal.pone.0032369.

7.

Children who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysis.

Becquet R, Marston M, Dabis F, Moulton LH, Gray G, Coovadia HM, Essex M, Ekouevi DK, Jackson D, Coutsoudis A, Kilewo C, Leroy V, Wiktor SZ, Nduati R, Msellati P, Zaba B, Ghys PD, Newell ML; UNAIDS Child Survival Group..

PLoS One. 2012;7(2):e28510. doi: 10.1371/journal.pone.0028510.

8.

AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire.

Anglaret X, Minga A, Gabillard D, Ouassa T, Messou E, Morris B, Traore M, Coulibaly A, Freedberg KA, Lewden C, Ménan H, Abo Y, Dakoury-Dogbo N, Toure S, Seyler C; ANRS 12222 Morbidity/Mortality Study Group..

Clin Infect Dis. 2012 Mar 1;54(5):714-23. doi: 10.1093/cid/cir898.

9.

Broad neutralization coverage of HIV by multiple highly potent antibodies.

Walker LM, Huber M, Doores KJ, Falkowska E, Pejchal R, Julien JP, Wang SK, Ramos A, Chan-Hui PY, Moyle M, Mitcham JL, Hammond PW, Olsen OA, Phung P, Fling S, Wong CH, Phogat S, Wrin T, Simek MD; Protocol G Principal Investigators., Koff WC, Wilson IA, Burton DR, Poignard P.

Nature. 2011 Sep 22;477(7365):466-70. doi: 10.1038/nature10373.

10.

CD4 cell eligibility thresholds: an analysis of the time to antiretroviral treatment in HIV-1 seroconverters.

Minga AK, Lewden C, Gabillard D, Bomisso GI, Toni TD, Emième AA, Yapo V, Inwoley A, Salamon R, Anglaret X; Agence Nationale de Recherches sur le Sida (ANRS) 1220 Primo-CI Study Group..

AIDS. 2011 Mar 27;25(6):819-23. doi: 10.1097/QAD.0b013e32834625d3.

11.

Short communication: Severe symptomatic hyperlactatemia among HIV type 1-infected adults on antiretroviral therapy in Côte d'Ivoire.

Minga A, Lewden C, Dohoun L, Abo Y, Emieme A, Coulibaly A, Salamon R, Eholié S, Anglaret X, Danel C; ANRS 1220 Primo-CI Study Group..

AIDS Res Hum Retroviruses. 2010 Sep;26(9):991-5. doi: 10.1089/aid.2009.0309.

12.

Comparison of early CD4 T-cell count in HIV-1 seroconverters in Côte d'Ivoire and France: the ANRS PRIMO-CI and SEROCO cohorts.

Lewden C, Thiébaut R, Boufassa F, Coulibaly A, Malateste K, Seng R, Toni TD, Inwoley A, Rouzioux C, Minga A, Anglaret X, Meyer L.

J Acquir Immune Defic Syndr. 2010 Feb;53(2):260-5. doi: 10.1097/QAI.0b013e3181b84260.

PMID:
19745754
13.

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target.

Walker LM, Phogat SK, Chan-Hui PY, Wagner D, Phung P, Goss JL, Wrin T, Simek MD, Fling S, Mitcham JL, Lehrman JK, Priddy FH, Olsen OA, Frey SM, Hammond PW; Protocol G Principal Investigators., Kaminsky S, Zamb T, Moyle M, Koff WC, Poignard P, Burton DR.

Science. 2009 Oct 9;326(5950):285-9. doi: 10.1126/science.1178746.

14.

Medium-term probability of success of antiretroviral treatment after early warning signs of treatment failure in West African adults.

Danel C, Gabillard D, Inwoley A, Chaix ML, Toni TD, Moh R, Messou E, Bissagnene E, Salamon R, Eholie S, Anglaret X.

AIDS Res Hum Retroviruses. 2009 Aug;25(8):783-93. doi: 10.1089/aid.2009.0018.

PMID:
19619008
15.

Relationship of CD4+ T-cell counts and plasma HIV-1 RNA levels with serological HBeAg/anti-HBe patterns obtained in West-African HBV-HIV-1-co-infected children.

Rouet F, Chaix ML, Kpozehouen A, Inwoley A, Anaky MF, Fassinou P, Rouzioux C, Blanche S, Msellati P.

J Trop Pediatr. 2009 Dec;55(6):409-12. doi: 10.1093/tropej/fmp034.

PMID:
19447821
16.

Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm.

Simek MD, Rida W, Priddy FH, Pung P, Carrow E, Laufer DS, Lehrman JK, Boaz M, Tarragona-Fiol T, Miiro G, Birungi J, Pozniak A, McPhee DA, Manigart O, Karita E, Inwoley A, Jaoko W, Dehovitz J, Bekker LG, Pitisuttithum P, Paris R, Walker LM, Poignard P, Wrin T, Fast PE, Burton DR, Koff WC.

J Virol. 2009 Jul;83(14):7337-48. doi: 10.1128/JVI.00110-09.

17.

Anthropometric and immunological success of antiretroviral therapy and prediction of virological success in west African adults.

Messou E, Gabillard D, Moh R, Inwoley A, Sorho S, Eholié S, Rouet F, Seyler C, Danel C, Anglaret X.

Bull World Health Organ. 2008 Jun;86(6):435-42.

18.

CD4+ T-lymphocytes natural decrease in HAART-naïve HIV-infected adults in Abidjan.

Duvignac J, Anglaret X, Kpozehouen A, Inwoley A, Seyler C, Toure S, Gourvellec G, Messou E, Gabillard D, Thiébaut R.

HIV Clin Trials. 2008 Jan-Feb;9(1):26-35. doi: 10.1310/hct0901-26.

PMID:
18215979
19.

Morbidity before and after HAART initiation in Sub-Saharan African HIV-infected adults: a recurrent event analysis.

Seyler C, Messou E, Gabillard D, Inwoley A, Alioum A, Anglaret X.

AIDS Res Hum Retroviruses. 2007 Nov;23(11):1338-47. doi: 10.1089/aid.2006.0308.

PMID:
18184075
20.

Frequent occurrence of chronic hepatitis B virus infection among West African HIV type-1-infected children.

Rouet F, Chaix ML, Inwoley A, Anaky MF, Fassinou P, Kpozehouen A, Rouzioux C, Blanche S, Msellati P; Programme Enfant Yopougon (Agence Nationale de Recherches sur le SIDA et les Hépatites Virales B et C 1244/1278)..

Clin Infect Dis. 2008 Feb 1;46(3):361-6. doi: 10.1086/525531.

Items per page

Supplemental Content

Loading ...
Support Center